Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs

被引：0
|
作者：
Behnaz Yousefghahari
Sanaz Navari
Mahmoud Sadeghi
Shima Soleimaniamiri
Mohammadjafar Soleimaniamiri
Behzad Heidari
Mansour Babaei
Kian Ghodrati
Ardeshir Guran
Hemmat Gholinia
机构：
[1] Babol University of Medical Sciences,Clinical Research Development Unit of Rohani Hospital
[2] Babol University of Medical Sciences,undefined
[3] Razi Labratory,undefined
[4] Wilfrid Laurier University,undefined
[5] Institute of Structronics,undefined
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
COVID-19; Disease-modifying anti-rheumatic drugs; Hydroxychloroquine; Infection risk; Rheumatic patients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4309 / 4315
页数：6
相关论文
共 50 条
  • [1] Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs
    Yousefghahari, Behnaz
    Navari, Sanaz
    Sadeghi, Mahmoud
    Soleimaniamiri, Shima
    Soleimaniamiri, Mohammadjafar
    Heidari, Behzad
    Babaei, Mansour
    Ghodrati, Kian
    Guran, Ardeshir
    Gholinia, Hemmat
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4309 - 4315
  • [2] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    D'Silva, Kristin M.
    Wallace, Zachary S.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2021, 23 (05)
  • [3] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    Kristin M. D’Silva
    Zachary S. Wallace
    [J]. Current Rheumatology Reports, 2021, 23
  • [4] Pharmacogenetics of disease-modifying anti-rheumatic drugs
    Tanaka, E
    Taniguchi, A
    Urano, W
    Yamanaka, H
    Kamatani, N
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (02): : 233 - 247
  • [5] Disease-modifying anti-rheumatic drugs - Cyclosporin
    Chaudhuri, K
    Torley, H
    Madhok, R
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 1016 - 1021
  • [6] Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs
    Akhil Sood
    Mukaila A. Raji
    [J]. Clinical Rheumatology, 2021, 40 : 1221 - 1231
  • [7] Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs
    Sood, Akhil
    Raji, Mukaila A.
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1221 - 1231
  • [8] A call for guidance on the treatment of patients taking disease-modifying anti-rheumatic drugs (DMARDs)
    Dickson, Kirsty Skye
    Regan, Alasdair
    Wemyss, Callum
    Paley, Martin
    Siddiqui, Arshad
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2024, 62 (04): : 389 - 390
  • [9] GUIDELINE ON CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Galloway, James
    [J]. RHEUMATOLOGY, 2016, 55 : 14 - 14
  • [10] Disease-modifying anti-rheumatic drugs as a risk factor for delayed DBS implant infection
    Oses, Marta
    Ordas, Carlos M.
    Feliz, Cici
    del Val, Javier
    Ayerbe, Joaquin
    Garcia-Ruiz, Pedro J.
    [J]. PARKINSONISM & RELATED DISORDERS, 2018, 55 : 143 - 144
12345